Fueling the growth of extraordinary ideas

Harbright invests in disruptive innovation that positively impacts people and the planet.

Harbright For Investors

Value Driven Approach

Harbright’s core mission is to bring value to our shareholders and we continue to build around a foundation that includes:

Opportunities

Harbright’s connections to world class universities and centers of innovation provide a steady stream of cutting edge, early-stage companies.

Team Expertise

Harbright’s leadership and bench of strategic advisors allow us to better screen, diligence, and advise our portfolio.

Structured Approach

Harbright’s proprietary Real-WIN-Worth due diligence framework clarifies and improves the decision-making process.

Harbright For Entrepreneurs

Partnership with a Purpose

Harbright helps address your company’s unique needs from investment to exit. Our support includes:

Capital Resources

Success often comes down to having capital when you need it. Harbright is laser focused on ensuring that resources are in place to enable success.

Connections

A single introduction can make all the difference. Harbright works to make strategic connections to customers, suppliers, talent, and others that can add value.

Guidance

Advice is only as good as the understanding behind it. We strive to listen first and provide direction based on our experience.

Harbright Portfolio Companies are the best example of what we’re about.

Advancements in medicine that will save and improve lives. Technology that makes the planet cleaner and greener. Software, products, and services that make businesses significantly more productive and efficient. Our portfolio companies are making a difference.

Invicta Water is eliminating PFAS chemicals from our water more completely and at less cost.

Invicta's low-cost remediation of PFAS ('forever chemicals') allows municipalities to provide clean water to its citizens at an affordable price.

VQ Biomedical’s supplemental oxygen tech will save tens of thousands of lives per year.

VQ's tech provides a bridge to survival for acute respiratory distress syndrome (ARDS) patients where mechanical ventilation falls short and ECMO is unavailable.

PLU Ophthalmic is making glaucoma surgery, faster, safer, and more accessible.

PLU's novel surgical device rapidly reduces IOP in Glaucoma patients with more predictable results and fewer risks than MIGS or traditional Trabeculectomy.

Investment Focus

Harbright invests in businesses where our capital base, industry relationships and extensive network of strategic advisors significantly strengthen a company’s outlook and enhance value.

Harbright is sector agnostic but we see outsized deal flow in these areas.